IFU
DGX icon

iSAM Funds (UK)’s Quest Diagnostics DGX Stock Holding History

iSAM Funds (UK)’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,768
Closed -$307K – 337
2025
Q4 		$307K Sell
1,768
-5,945
-77% -$1.08M 0.11% 219
2025
Q3 		$1.47M Buy
+7,713
New +$1.37M 0.3% 94
2025
Q2 		– Sell
-9,005
Closed -$1.52M – 483
2025
Q1 		$1.52M Buy
+9,005
New +$1.48M 0.75% 25
2024
Q2 		– Sell
-5,657
Closed -$753K – 265
2024
Q1 		$753K Buy
+5,657
New +$734K 0.43% 85

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

iSAM Funds (UK)'s DGX Position: Q1 2026 in Review

iSAM Funds (UK) sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 1,768 shares — an estimated $307K sold.

iSAM Funds (UK) first reported a position in DGX in Q1 2024 and held it in 4 quarters. The position peaked at $1.52M in Q1 2025. 1,069 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • iSAM Funds (UK) reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • iSAM Funds (UK) sold 1,768 Quest Diagnostics shares in Q1 2026, an estimated $307K.
  • iSAM Funds (UK) first reported a position in Quest Diagnostics in Q1 2024 and held it in 4 quarters.
  • iSAM Funds (UK)'s Quest Diagnostics position peaked at $1.52M in Q1 2025.
  • 1,069 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on iSAM Funds (UK)'s 13F filing for Q1 2026, filed 13 May 2026.